Abstract:
The present invention provides a method of inducing myelination of isolated motoneurons by preparing a non-biological substrate having thereon a covalently attached monolayer of DETA; depositing isolated motoneurons on the substrate in a defined serum-free medium; plating isolated Schwann cells cultured in the defined serum-free medium onto the motoneurons, thereby initiating a co-culture; and passaging the co-culture as necessary into fresh, defined serum-free medium supplemented with L-ascorbic acid at least until the motoneurons form Nodes of Ranvier indicative of myelination. The invention also includes a method of testing for new drugs effective in demyelinating diseases. Additionally, cellular products provided by the invention include an isolated motoneurons myelinated or remyelinated in vitro according to the methods disclosed.

Description:
RELATED APPLICATION 
     This application claims priority from provisional application Ser. No. 61/181,737, which was filed on 28 May 2009, and which is incorporated herein by reference in its entirety. 
    
    
     STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT 
     This invention was made with government support under R01 NS050452 awarded by the National Institutes of Health. The government has certain rights in the invention. 
    
    
     FIELD OF THE INVENTION 
     The present invention relates to the field of neurodegenerative diseases and, more particularly, to an in vitro co-culture of motoneurons and Schwann cells which promotes the survival, maturation and myelinization of the motoneurons with subsequent complete node of Ranvier formation. 
     BACKGROUND OF THE INVENTION 
     The rapid conduction of action potentials in both the central nervous system (CNS) and peripheral nervous system (PNS) depends on the formation of a myelin sheath around neuronal axons. In the PNS, myelination initiation requires an interaction between Schwann cells and an individual axon, a process known as radial sorting [1]. During myelination, Schwann cells form an insulating, multilamellar sheath around associated axonal segments, resulting in the formation of four specialized domains: the internode, the juxtaparanode, the paranodal region and the Node of Ranvier. In the internode, axons are ensheathed by compact myelin consisting of the Schwann cell membrane and expressed myelin basic protein (MBP). The juxtaparanodal region sits adjacent to the paranode and contains localized clusters of voltage-gated potassium channels (vgpc&#39;s) in the axon. In the paranodal region, the axon and myelin sheath form axo-glial junctions where Schwann cells express neurofascin 155 form heterodimers along with axonal protein contactin-associated protein (CASPR) [2]. At the Nodes of Ranvier, which are specialized regions of unmyelinated axon between two myelin segments, the presence of clusters of voltage-gated sodium channels (vgsc&#39;s) facilitate the saltatory conduction of action potentials [3]. 
     Model systems that can represent the myelination of motoneurons by glial cells have previously proven difficult to develop. Myelination of neurons by Schwann cells has been extensively studied using dorsal root ganglia (DRG) cultures in a variety of serum containing and serum-free in vitro systems [4]. However, while many groups have reported the successful co-culture of primary motoneurons and Schwann cells, the success of myelinating sensory neuron systems has not been translated to motoneuron systems [5-10]. The development of a functional myelinating motoneuron/Schwann cell system is a necessary first step in describing the molecular events surrounding the interactions between these cells that have myelination as the end result. Additionally, such a system would benefit scientists&#39; ability to study both central and peripheral demyelinating neuropathies such as multiple sclerosis, Guillain-Barré Syndrome, diabetes associated peripheral neuropathies and progressive muscular atrophy, under controlled conditions. Previous studies have described methods to create defined systems to understand hippocampal function [11] and motoneuron regeneration [12]. The adaptation of these culture systems to motoneurons/Schwann cell co-culture would be an ideal solution to this problem. 
     SUMMARY OF THE INVENTION 
     One of the most significant interactions between Schwann cells and neurons is myelin sheath formation. Myelination is a vertebrate adaptation that enables rapid conduction of action potentials without a commensurate increase in axon diameter. In vitro neuronal systems provide a unique modality to study both factors influencing myelination and diseases associated with myelination. Currently, no in vitro system for motoneuron myelination by Schwann cells has been demonstrated. This work details the myelination of motoneuron axons by Schwann cells, with complete Node of Ranvier formation, in a defined in vitro culture system. This defined system utilizes a novel serum-free medium in combination with the non-biological substrate, N-1[3(trimethoxysilyl)propyl]diethylenetriamine (DETA). It should be understood that the substrate is also referred to herein as a surface. The myelinated segments and nodal proteins were visualized and quantified using confocal microscopy. This defined system provides a highly controlled, reproducible model for studying Schwann cell interactions with motoneurons as well as the myelination process and its effect on neuronal plasticity. Furthermore, an in vitro system that would allow studies of motoneuron myelination would be beneficial for understanding peripheral demyelinating neuropathies such as diabetes induced peripheral neuropathy and could lead to a better understanding of CNS demyelinating diseases like multiple sclerosis, as well as neuromuscular junction maturation and maintenance. 
     With the foregoing in mind, the present invention advantageously discloses a system for the myelination of motoneurons in a chemically defined, serum-free medium on the biomimetic, non-biological substrate N-1[3(trimethoxysilyl)propyl]diethylenetriamine (DETA). The utility of this substrate comes from its ability to form a self-assembled monolayer on any hydroxalated surface [13], the ease of photolithographic patterning [14] and the postulation that cells do not degrade this surface modification due to its non-biological origins and covalent attachment to the surface [11, 15]. In the defined medium we have identified the minimum combination of growth factors required for neuronal growth, as well as Schwann cell survival, proliferation and myelination of motoneuron axons that results in complete Node of Ranvier formation. System maturation was determined by analysis of the clustering of voltage-gated sodium (vgsc&#39;s) and potassium channels (vgpc&#39;s) at the nodes as well as from the presence of contactin-associated protein (CASPR). This defined system provides a reproducible model for studying Schwann cell interactions with motoneurons as well as the myelination process, and most importantly, remyelination. 
     Accordingly, the present invention provides a method of inducing myelination of isolated motoneurons. A preferred method of the invention includes preparing a non-biological substrate having thereon a covalently attached monolayer of DETA; depositing isolated motoneurons on the substrate in a defined serum-free medium; plating isolated Schwann cells cultured in the defined serum-free medium onto the motoneurons, thereby initiating a co-culture; and passaging the co-culture as necessary into fresh, defined serum-free medium supplemented with L-ascorbic acid at least until the motoneurons form Nodes of Ranvier indicative of myelination. 
     Another preferred embodiment of the invention includes a method of making myelinated motoneurons in vitro, the method comprising co-culturing isolated motoneurons and Schwann cells in a defined serum-free medium on a biomimetic monolayer supported on a surface; and passaging the co-culture as necessary into fresh medium supplemented with L-ascorbic acid until the motoneurons are myelinated and Nodes of Ranvier are formed thereon. 
     Additional variations of the invention include wherein the biomimetic monolayer in the method comprises a non-biological substrate of N-1[3(trimethoxysilyl)propyl]diethylenetriamine (DETA). Further, the method may also have a surface that comprises glass and the biomimetic monolayer may be patterned, particularly by photolithography. The biomimetic monolayer is preferably covalently attached to the surface. 
     Cellular products provided by the invention include an isolated motoneuron myelinated in vitro according to the methods disclosed. Also included in these products is a culture of motoneurons myelinated in vitro according to the given methods, and a mixed culture of isolated Schwann cells and motoneurons in a defined serum-free medium, wherein the motoneurons are myelinated. It should be understood that the presently described methods are equally useful in remyelinating disfunctional motoneurons. 
     The invention also includes a method of drug discovery in a demyelinating disease. This method embodiment includes co-culturing isolated motoneurons having a myelination deficit together with isolated normal Schwann cells in a defined serum-free medium on a biomimetic monolayer supported on a surface. The co-culture is contacted with a drug candidate being evaluated for effectiveness in reestablishing normal myelination. The co-culture is passaged as necessary into fresh medium supplemented with L-ascorbic acid. The drug&#39;s effectiveness is then evaluated by monitoring the motoneurons for myelination and formation of Nodes of Ranvier thereon. 
    
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
       The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee. 
       Some of the features, advantages, and benefits of the present invention having been stated, others will become apparent as the description proceeds when taken in conjunction with the accompanying drawings in which: 
         FIG. 1  shows XPS and contact angle analysis of DETA monolayer on glass coverslips: (A) XPS survey spectra analysis of the DETA coverslip, (B) XPS high resolution spectrum of N1s peak on DETA coverslip, (C) XPS high resolution spectrum of Si2p peak on DETA coverslip, (D) contact angle image of water on a DETA coverslip; 
         FIG. 2  depicts phase contrast images of motoneuron+Schwann cell co-cultures; (A) EMN culture image at day 7, (B) pure neonatal Schwann cell culture at day 14 (C) EMN+SC co-culture at day 7 (arrow indicating MN); scale bars=60 μm; 
         FIG. 3  provides the immunocytochemical evaluation of the myelination of motoneurons by Schwann cells; (A-D) embryonic MN+SC co-culture images at day 29, (A) phase contrast image of the MN+SC co-culture, (B) NF-H antibody staining of neuronal processes throughout the culture, (C) MBP antibody staining showing a segment of compact myelin and the outline of the Schwann cell. (D) merge image showing the co-localization of the NF-H and MBP antibody staining. (E-H) embryonic MN+SC culture images at day 27, (E) phase contrast image of the MN+SC co-culture, (F) NF-H antibody staining showing neuronal processes, (G) MBP antibody staining revealing a segment of compact myelin in the culture, (H) merge image indicating co-localization of the NF-H and MBP antibody staining; scale bars=50 μm; 
         FIG. 4  shows the immunocytochemical characterization of Node of Ranvier formation on motoneurons; (A) phase contrast image of day 29 MN+SC co-culture showing an axonal segment and multiple Schwann cell bodies, (B) MBP and vgsc staining indicating node formation, (C) CASPR staining indicating paranode formation, (D) vgpc staining indicating juxtaparanode formation; scale bar=50 μm; 
         FIG. 5  shows a flow diagram of a preferred method of the invention; and 
         FIG. 6  depicts a flow diagram of another preferred method of the invention. 
     
    
    
     DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT 
     The present invention will now be described more fully hereinafter with reference to the accompanying drawings, in which preferred embodiments of the invention are shown. 
     Unless otherwise defined, all technical and scientific terms used herein are intended to have the same meaning as commonly understood in the art to which this invention pertains and at the time of its filing. Although various methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described below. However, the skilled should understand that the methods and materials used and described are examples and may not the only ones suitable for use in the invention. 
     Moreover, it should also be understood that as measurements are subject to inherent variability, any temperature, weight, volume, time interval, pH, salinity, molarity or molality, range, concentration and any other measurements, quantities or numerical expressions given herein are intended to be approximate and not exact or critical figures unless expressly stated to the contrary. Hence, where appropriate to the invention and as understood by those of skill in the art, it is proper to describe the various aspects of the invention using approximate or relative terms and terms of degree commonly employed in patent applications, such as: so dimensioned, about, approximately, substantially, essentially, consisting essentially of, comprising, and effective amount. 
     Further, any publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety as if they were part of this specification. However, in case of conflict, the present specification, including any definitions, will control. In addition, the materials, methods and examples given are illustrative in nature only and not intended to be limiting. 
     Accordingly, this invention may be embodied in many different forms and should not be construed as limited to the illustrated embodiments set forth herein. Rather, these illustrated embodiments are provided so that this disclosure will be thorough, complete, and will fully convey the scope of the invention to those skilled in the art. Other features and advantages of the invention will be apparent from the following detailed description, and from the claims. 
     Materials and Methods 
     DETA Surface Preparation and Characterization 
     Glass coverslips (VWR 48366067, 22×22 mm 2  No. 1) were first cleaned using 1:1 HCl-methanol followed by a concentrated H2SO4 soak for 2 h. The DETA (United Chemical Technologies Inc. T2910-KG) film was formed by the reaction of the cleaned surfaces with a 0.1% (v/v) mixture of the organosilane in freshly distilled toluene (VWR BDH1151). The cleaned surfaces were heated to about 100° C. in the organosilane mixture, rinsed with toluene, reheated to about 100° C. in toluene, and then dried in the oven overnight (100° C.). Surfaces were characterized by static water contact angle measurements using a Rame-Hart Model 250 goniometer, and by X-ray photoelectron spectroscopy (XPS) using an Escalab 200i spectrometer (VG Scientific) by monitoring the N1s peak [15-17]. The values are reported as the mean±SEM. 
     Animals 
     Dated pregnant Sprague-Dawley rats were housed in an animal facility at the University of Central Florida. All research was approved by the Institutional Animal Care and Use Committee at the University of Central Florida and conformed to NIH guidelines. Pregnant rats were anesthetized and sacrificed at embryonic day 15, embryos were removed by caesarean section and fetuses dissected under a stereo microscope (Carl Zeiss, Stemi, 2000). 
     Purified Embryonic Motoneuron Culture 
     Rat spinal cord motoneurons were purified from the ventral horn cords from embryonic day 15 (E15) embryos as described by Henderson et al. [18]. Briefly, pregnant rats were anaesthetized and killed by inhalation of excess CO 2 . Spinal cords were removed from the E15 pups and the ventral horn tissue was dissected out and digested in 0.05% trypsin-EDTA for 15 min in a 37° C. water bath (Gibco 25300-120). Following incubation, the trypsin-EDTA was aspirated and the cells suspended in dissection media             10% FBS and the tissue gently triturated. The dissociated cell suspension was then centrifuged at 500 g for 10 min at 4° C. to pellet the cells. Next, the tissue was layered on a density gradient of Opti-prep (Sigma D1556) solution and centrifuged at 500 g for 15 min at 4° C. After centrifugation, the resulting top two bands were collected in a 15 ml tube and the pellet discarded. The ventral horn cells were then applied to an immuopanning dish coated with goat affinity purified antibody to rat IgG and the low affinity nerve growth factor receptor p75 (Chemicon MAB365) in dissection medium for 45 min. This positive selection process provides attachment for the motoneurons while the other cells remain in suspension. After immuopanning the non-adherent cells were aspirated and the adherent motoneurons were removed from the dish in dissection medium to a 15 ml tube. Lastly, the neurons were pelleted by centrifugation at 500 g for 10 min and then resuspended in culture medium and plated at 100 cells/mm 2  (Table 1).
     Neonatal Schwann Cell Culture 
     Primary rat Schwann cells (SC) were cultured from neonatal rat sciatic nerves as described originally by Brockes et al. [19]. Briefly, sciatic nerves from newly born Sprague-Dawley (Charles River: Raleigh, N.C.) rat pups were dissected from the hind limb and then digested with 0.3% collagenase in Dulbecco&#39;s modified Eagle&#39;s medium (DMEM)+10% FBS, forskolin and pituitary extract on poly-L-lysine coated 100 mm tissue culture dishes. After two days in culture, fibroblasts were eliminated using Thy1.1 antibody/complement mediated lysis (Chemicon MAB1406). Purified SC cultures were passaged no more than three times before plating with the embryonic motoneurons for the myelination experiments. 
     Immunocytochemistry &amp; Laser Scanning Confocal Microscopy 
     The co-cultures were fixed in fresh 4% paraformaldehyde in PBS for 5 min and then rinsed twice with PBS. Next, cells were permeabilized with a solution of 0.5% Triton-X 100 in PBS+5% bovine serum albumin (BSA) for 5 min. rinsed once with PBS and then blocked with permeabilization solution+5% donkey serum. The cells were then incubated with primary antibody solutions in blocking buffer overnight at 4° C. The following primary antibodies were obtained commercially from Chemicon: anti-neurofilament heavy chain (1:12,000) (AB5539), anti-voltage-gated sodium channel pan (1:200) (AB5210), anti-voltage gated potassium channel (1:200) (AB5483) and MBP (1:40) (MAB382). The anti-CASPR antibody (1:500) (sc-14340) was obtained from Santa Cruz Biotechnology, Inc. The next day primary antibody solutions were aspirated and the cells rinsed three times with PBS. Then, Alexa-Fluor 488 nm, 594 nm and 647 nm secondary antibodies diluted 1:200 in blocking solution were added to the cells and incubated for 2 h at room temperature in the dark. The secondary antibody solution was then aspirated and the coverslips rinsed three times in PBS and allowed to dry. Finally, coverslips were mounted on glass slides using VectaShield mounting medium with DAPI (Vector Labs, H-1200) and fixed using clear nail polish. 
     Results 
     DETA Surface Modification 
     The aminosilane, trimethoxy-silylpropyl-diethylenetriamine (DETA), functions efficiently as a non-biological substrate due to its self-assembling monolayer properties and the multiple amines contained in the terminal group. This group confers hydrophilic properties to the surface, and that combined with the partial positive change on the amines at physiological pH make it an ideal surface for neuronal cellular attachment and survival. The system is similar to poly-D-lysine, but has been found to be more robust and consistent [11]. XPS measurements of the DETA coated coverslips indicated a complete monolayer formed during the self-assembly process ( FIG. 1 ). The normalized area values of N1s (401 and 399 eV) to the Si 2p 3/2  peaks were stable throughout the study at 1500 200 and were similar to previously published results ( FIG. 1A-C ) [11, 14, 15, 17, 20]. Static contact angle measurements of 45.6±2 validated the hydrophilicity of the DETA surfaces ( FIG. 1D ). Stable XPS readings and contact angles across coverslips throughout the study indicate uniformity and reproducibility of the self-assembly of the DETA monolayer. 
     Myelination Promoting Medium Formulation 
     As previously reported, embryonic and adult motoneurons, grown in serum-free medium on DETA recovered morphologically and electrically, firing repetitive action potentials under patch clamp conditions [12]. In this study, rat motoneurons and Schwann cells were isolated and grown in serum-free medium on DETA substrates. The defined medium formulation described in Table 1 supported the growth and development of motoneurons and Schwann cells as shown in  FIG. 2 . Rat motoneurons and Schwann cells were first individually isolated and grown separately as controls to ensure suitable morphology. In the individual cultures these motoneurons developed a singular axonal process and branching dendritic field ( FIG. 2A ). Schwann cells exhibited a spindle-like morphology characteristic of this cell type ( FIG. 2B ). Cultured together, motoneurons and Schwann cells exhibited similar morphologies to the individual cultures ( FIG. 2C ). Furthermore, with the temporal supplementation of ascorbic acid, Schwann cells formed myelin sheaths and this also resulted in the subsequent clustering of the nodal proteins ( FIGS. 3 and 4 ). 
     Immunocytochemical Evaluation and Quantification of Myelination 
     As compact myelin forms around neuronal axons, Schwann cells express MBP as a component of the myelin sheath. Using immunocytochemistry, MBP expression was evaluated as a standard for compact myelin formation in the culture system for day 25 to day 30. The neuronal processes were imaged using anti-neurofilament-H(NF-H) antibodies and then the fluorescence co-localization was determined using the two antibodies. Myelin segments were observed in motoneuron+Schwann cell co-cultures ( FIG. 3 ). After staining, myelin segments were quantified in order to determine the efficiency of Schwann cell myelination in the co-culture system. As shown in Table 2, 63.11±1.70 myelinated segments per coverslip were identified in the motoneuron+Schwann cell co-culture. 
     Additionally, myelination resulted in the rearrangement and clustering of voltage-gated sodium channels (vgsc&#39;s) and voltage-gated potassium channels (vgpc&#39;s) in the axonal segment. This clustering resulted in the formation of physiologically correct Nodes of Ranvier as defined below. 
     Node of Ranvier Formation 
     In order to visualize nodal development in this system, immunocytochemistry was used to stain for vgsc&#39;s, vgpc&#39;s and CASPR localized at the nodes. As shown in  FIG. 4 , vgsc&#39;s were found clustered between two myelinated segments of a motoneuron axon, verifying Node of Ranvier formation (FIGS.  4 A,B). Additionally, clusters of CASPR ( FIG. 4C ) and vgpc&#39;s ( FIG. 4D ) were also seen in this culture system. The presence of these nodal proteins indicates maturation of the nodes into the physiologically correct morphologies. After staining, the number of nodes was quantified in order to determine the efficiency of Schwann cell myelination and node formation in the co-culture system. As shown in Table 2, the formation of 20.67±0.61 Nodes of Ranvier was identified per coverslip. 
     Discussion 
     The development of an in vitro system defining the minimum requirements for the survival, maturation and myelination of a motoneuron+Schwann cell co-culture represents a significant scientific and technological breakthrough. These experiments indicate that this medium formulation is sufficient to not only recover cellular functionality, but also to provide an environment conducive to further cell-cell interactions and relevant physiological development that results in physiologically correct Node of Ranvier formation. Using this basic serum-free medium formulation we have also shown the ability to grow dorsal root ganglia sensory neurons and both intrafusal and extrafusal muscle fibers [21-23]. The ability of the same basic serum-free medium formulation to sustain growth and facilitate myelination of a variety of interacting cell types facilitates future studies where all cells could be combined (Table 1). For example, studying motoneuron/sensory neuron electrical connectivity or recreating the stretch reflex arc in vitro will require all of these cell types to be in close proximity and will be more easily achieved using one basic medium formulation. This also is an essential requirement for drug discovery applications. Furthermore, the reported importance of culturing motoneurons, sensory neurons and Schwann cells together with muscle to form a significant number of neuromuscular junctions in vitro makes this basic medium even more critical [24, 25]. 
     Schwann cell interaction with axons in the periphery is essential for efficient myelin sheath formation. Here we have shown both myelin sheath formation and subsequent development of Nodes of Ranvier using this defined in vitro system ( FIGS. 3 and 4 ). The quantity of myelinated segments relative to Nodes of Ranvier indicate that not all myelinated segments formed in such a fashion as to result in the clustering of nodal proteins. While the processing of nodal proteins is influenced by the presence of myelinating Schwann cells opposing the initial segment, it is not known what regulates the Schwann cell “decision” to elongate an initial myelin segment or begin the process of forming a new segment. The likely candidate are interactions between the motoneuron and the extra-nodal proteins of the myelinating Schwann cell [26]. Due to the significant level of physiological development, the system also provides a model for further investigation into the potential molecular differences between Schwann cell interaction with motoneurons and sensory neurons. For example, it could be useful in the evaluation of additional factors that could play a role in enhancing motoneuron myelination and node formation relative to sensory neurons. This is especially true for evaluating factors that are normally abundant in serum infused medium formulations typically used to facilitate Schwann cell myelination of sensory neurons. 
     DETA&#39;s utility from a bioengineering standpoint stems from its defined and reproducible nature. Its role here, as a biomimetic, hydrophilic growth substrate, is especially useful because we believe it is not degraded by the cells plated on it and because it easily facilitates the study of deposited extracellular matrix molecules on the growth surface by the cells. DETA can be coated onto any hydroxylated surface or material. All of these features make DETA a useful substrate for bioengineering applications, a major goal in hybrid electronic systems, tissue engineering and cell-based biosensors. Consequently, DETA coated micro-electro-mechanical systems (MEMS) devices like multi-electrode arrays (MEAs) can provide a high throughput system for evaluating the electrical differences between myelinated and non-myelinated neurons. As previous studies have indicated, the deposition of a basal lamina and the subsequent modification of that layer are required for the formation of Schwann cell myelin [6, 7, 27]. Therefore, the use of DETA as the growth substrate for these experiments suggests that the neurons and/or the Schwann cells are secreting sufficient extracellular matrix (ECM) components necessary for the formation of the myelin sheath. This raises the questions of which cells generate the basal lamina, which cells secrete what ECM proteins, and how the ECM deposition influences cell-cell interaction between neurons and Schwann cells. These questions are currently under investigation in our laboratory. 
     CONCLUSION 
     We have used a completely defined in vitro system to demonstrate Node of Ranvier formation by Schwann cells on motoneurons with concurrent K channel clustering and CASPR formation. The development of this system, one where motoneurons are myelinated by Schwann cells, is a critical breakthrough in understanding the interactions between these two cell types and represents significant progress towards culturing a stretch reflex arc in vitro [24, 28, 29]. Additionally, it provides a novel system to evaluate the utility of a variety of factors not easily analyzed using an in vivo model. Such a system could provide enhancement to or recovery of myelin segments for patients suffering from demyelinating neuropathies. This defined system provides a reproducible model for studying Schwann cell interactions with motoneurons as well as the myelination process, and most importantly, remyelination. 
     Accordingly, in the drawings and specification there have been disclosed typical preferred embodiments of the invention and although specific terms may have been employed, the terms are used in a descriptive sense only and not for purposes of limitation. The invention has been described in considerable detail with specific reference to these illustrated embodiments. It will be apparent, however, that various modifications and changes can be made within the spirit and scope of the invention as described in the foregoing specification and as defined in the appended claims. 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
               
             
           
               
                 TABLE 1 
               
             
             
               
                   
               
               
                 Serum free medium composition for growth and  
               
               
                 myelination of motoneurons by Schwann cells 
               
             
          
           
               
                   
                 Amount/ 
                   
                 Catalog 
               
               
                 Component 
                 Concentration 
                 Company 
                 Number 
               
               
                   
               
             
          
           
               
                 Neurobasal 
                 500 
                 mL 
                 Gibco 
                 10888 
               
               
                 B27 
                 50 
                 μL/ML 
                 Gibco 
                 17504-044 
               
               
                 Glutamax 
                 10 
                 μL/ML 
                 Invitrogen 
                 35050-061 
               
               
                 Antibiotic/Antimycotic 
                 10 
                 μL/mL 
                 Invitrogen 
                 15240-062 
               
               
                 aFGF 
                 20 
                 ng/mL 
                 Invitrogen 
                 13241-013 
               
               
                 VEGF 165 
                 20 
                 ng/mL 
                 Invitrogen 
                 P2654 
               
               
                 h BDNF 
                 20 
                 ng/mL 
                 Cell Sciences 
                 CRB 600B 
               
               
                 h GDNF 
                 20 
                 ng/mL 
                 Cell Sciences 
                 CRG 400B 
               
               
                 r CNTF 
                 50 
                 ng/mL 
                 Cell Sciences 
                 CRC 401B 
               
               
                 h CT-1 
                 20 
                 ng/mL 
                 Cell Sciences 
                 CRC 700B 
               
               
                 NT-3 
                 20 
                 ng/mL 
                 Cell Sciences 
                 CRN 500B 
               
               
                 NT-4 
                 20 
                 ng/mL 
                 Cell Sciences 
                 CRN 501B 
               
               
                 Heparin sulfate 
                 80 
                 ng/mL 
                 Sigma 
                 D9809 
               
               
                 Vitronectin 
                 100 
                 ng/mL 
                 Sigma 
                 V0132 
               
               
                   1 L-ascorbic acid 
                 50 
                 ng/mL 
                 Sigma-Aldrich 
                 396-HB 
               
               
                   
               
               
                   1 Supplemental component added only at indicated medium changes 
               
             
          
         
       
     
     
       
         
               
             
               
               
               
               
             
           
               
                 TABLE 2 
               
             
             
               
                   
               
               
                 Quantification of myelin segments and Nodes of Ranvier 
               
             
          
           
               
                   
                 Culture 1 
                 Culture 2 
                 Culture 3 
               
               
                   
               
               
                 Myelinated segments 
                 61.67 ± 3.71 
                 63.67 ± 4.91 
                 64.00 ± 2.65 
               
               
                 Nodes of Ranvier 
                 20.33 ± 0.88 
                 20.00 ± 1.73 
                 21.67 ± 1.20 
               
               
                   
               
               
                 The data shown is a mean of four coverslips evaluated per culture. 
               
               
                 The values are the mean ± the standard error of the mean (SEM). 
               
             
          
         
       
     
     REFERENCES 
     
         
         [1] Jessen K R, Mirsky R. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 2005; 6(9):671-82. 
         [2] Sherman D L, Tait S, Melrose S, Johnson R, Zonta B, Court F A. et al. Neurofascins are required to establish axonal domains for saltatory conduction. Neuron 2005; 48(5):737. 
         [3] Sherman D L, Brophy P J. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 2005; 6(9):683-90. 
         [4] Wood P, Moya F, Eldridge C F, Owens G, Ranscht B. Schachner M, et al. Studies of the initiation of myelination by Schwann cells. Ann N Y Acad Sci 1990; 605:1-14. 
         [5] Bahr M, Hopkins J M, Bunge R P. In vitro myelination of regenerating adult rat retinal ganglion cell axons by Schwann cells. Glia 1991; 4(5):529-33. 
         [6] Eldridge C F, Bunge M B, Bunge R P. Differentiation of axon-related Schwann cells in vitro: il. Control of myelin formation by basal lamina. 1989 Feb. 1. J Neurosci 1989:9(2):625-38. 
         [7] Fernandez-Valle C, Fregien N, Wood P M, Bunge M B. Expression of the protein zero myelin gene in axon-related Schwann cells is linked to basal lamina formation. 1993 Nov. 1. Development 1993; 119(3):867-80. 
         [8] Podratz J, Rodriguez E, Windebank A. Antioxidants are necessary for myelination of dorsal root ganglion neurons, in vitro. Glia 2004; 45(1):54-8. 
         [9] Ullian E M, Harris B T, Wu A, Chan J R, Barres B A. Schwann cells and astrocytes induce synapse formation by spinal motor neurons in culture. Mol Cell Neurosci 2004; 25:241-51. 
         [10] Windebank A J, Wood P, Bunge R P, Dyck P J. Myelination determines the caliber of dorsal root ganglion neurons in culture. 1985 Jun. 1. J Neurosci 1985; 5(6):1563-9. 
         [11] Schaffner A E, Barkerm J L, Stengerm D A, Hickman J J. Investigation of the factors necessary for growth of hippocampal neurons in a defined system. J. Neurosci Methods 1995; 62(1-2):111-9. 
         [12] Das M, Patil S, Bhargava N. Kang J-F, Riedel L, Seal S, et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007; 28(10):1918-25. 
         [13] Hickman J J. Bhatia S K, Quong J N, Shoen P, Stenger D A, Pike C J, et al. Rational pattern design for in-vitro cellular networks using surface photochemistry. J Vac Sci Technol A Vac Surf Films 1994; 12(3):607-16. 
         [14] Ravenscroft M S, Bateman K, Shaffer K. Developmental neurobiology implications from fabrication and analysis of hippocampal neuronal networks on patterned silane-modified surfaces. J Am Chem Soc 1998; 120(47):12169-77. 
         [15] Stenger D A, Pike C J, Hickman J J, Cotman C W. Surface determinants of neuronal survival and growth on self-assembled monolayers in culture. Brain Res 1993; 630(1-2):136-47. 
         [16] Spargo B J, Testoff M A, Nielsen T B, Stenger D A, Hickman J J, Rudolf A S. Spatially controlled adhesion, spreading, and differentiation of endothelial cells on selfassembled molecular monolayers. PNAS 1994 November 8; 91(23):11070-4. 
         [17] Stenger D A, Hickman J J, Bateman K E, Ravenscroft M S, Ma W, Pancrazio J J, et al. Microlithographic determination of axonal/dendritic polarity in cultured hippocampal neurons. J Neurosci Methods 1998; 82(2):167-73. 
         [18] Henderson C E, Bloch-Gallego E. CamuW. Purified embryonic motoneurons. In: Cohen J, Wilkin G, editors. Nerve cell culture: a practical approach. London, Oxford: University Press; 1995. p. 69-81. 
         [19] Brockes J P, Fields K L, Raff M C. Studies on cultured rat Schwann cells I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 1979; 165:105-18. 
         [20] Stenger D A, Georger J H, Dulcey C S, Hickman J J, Rudolph A S, Nielsen T B, et al. Coplanar molecular assemblies of amino- and perfluorinated alkylsilanes: characterization and geometric definition of mammalian cell adhesion and growth. J Am Chem Soc 1992; 114:8435-42. 
         [21] Das M, Gregory C A, Molnar P, Riedel L M, Wilson K, Hickman J J. A defined system to allow skeletal muscle differentiation and subsequent integration with silicon microstructures. Biomaterials 2006; 27(24):4374. 
         [22] Liu J, Rumsey J, Das M, Molnar P, Gregory C, Riedel L, et al. Electrophysiological and immunocytochemical characterization of DRG neurons on an organosilane surface in serum-free medium. In Vitro Cell Dev Biol Anim 2008; 44(5):162-8. 
         [23] Rumsey J W, Das M, Kang J F, Wagner R, Molnar P, Hickman J J. Tissue engineering intrafusal fibers: dose- and time-dependent differentiation of nuclear bag fibers in a defined in vitro system using neuregulin 1-beta-1. Biomaterials 2008; 29(8):994-1004. 
         [24] Guettier-Sigrist S, Coupin G, Warter J M, Poindron P. Cell types required to efficiently innervate human muscle cells in vitro. Exp Cell Res 2000; 259(1):204-12. 
         [25] Kobayashi T, Askanas V, Engel W K. Human muscle cultured in monolayer and cocultured with fetal rat spinal cord: importance of dorsal root ganglia for achieving successful functional innervation. J Neurosci 1987; 7(10): 3131-41. 
         [26] Melendez-Vasquez C V, Rios J C, Zanazzi G. Lambert S, Bretscher A, Salzer J L. Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes. Proc Natl Acad Sci USA 2001; 98(3):1235-40. 
         [27] Bunge R P. Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration. Curr Opin Neurobiol 1993 October; 3(5):805-9. 
         [28] Koirala S, Reddy L V, Ko C-P. Roles of glial cells in the formation, function, and maintenance of the neuromuscular junction. J Neurocytology 2003; 32:987-1002. 
         [29] Mars T, Yu K J, Tang X-M, Miranda A F, Grubic Z, Cambi F, et al. Differentiation of glial cells and motor neurons during the formation of neuromuscular junctions in cocultures of rat spinal cord explant and human muscle. J Comp Neurol 2001; 438:239-51.